Abstract
There is current debate concerning the use of angiotensin-converting enzyme (ACE) inhibitors or angiotensin II type 1 receptor blockers (ARBs), for hypertension management, during COVID-19 infection. Specifically, the suggestion has been made that ACE inhibitors or ARBs could theoretically contribute to infection via increasing ACE2 receptor expression and hence increase viral load. The ACE2 receptor is responsible for binding the SAR-CoV2 viral spike and causing COVID-19 infection. What makes the argument somewhat obtuse for ACE inhibitors or ARBs is that ACE2 receptor expression can be increased by compounds that activate or increase the expression of SIRT1. Henceforth common dietary interventions, vitamins and nutrients may directly or indirectly influence the cellular expression of the ACE2 receptor. There are many common compounds that can increase the expression of the ACE2 receptor including Vitamin C, Metformin, Resveratrol, Vitamin B3 and Vitamin D. It is important to acknowledge that down-regulation or blocking the cellular ACE2 receptor will likely be pro-inflammatory and may contribute to end organ pathology and mortality in COVID-19. In conclusion from the perspective of the ACE2 receptor, COVID-19 prevention and t...Continue Reading
References
Mar 8, 2005·The Journal of Biological Chemistry·Margie T BorraJohn M Denu
Oct 30, 2009·Journal of Virology·Ilona GlowackaStefan Pöhlmann
Oct 24, 2013·Clinical Science·Nicola E ClarkeAnthony J Turner
Apr 16, 2016·Circulation Research·Vaibhav B PatelGavin Y Oudit
Sep 26, 2017·Molecular Medicine Reports·Jun XuHong Zhang
Feb 7, 2018·Atherosclerosis·Eun Nim KimBum Soon Choi
Apr 21, 2018·Biochemical and Biophysical Research Communications·Meng-Zhi QiEn-Qiang Mao
May 29, 2018·Free Radical Biology & Medicine·Guangliang HongTianqing Peng
Nov 22, 2018·Frontiers in Endocrinology·Elisabet CuyàsJavier A Menendez
Oct 2, 2019·Rejuvenation Research·Firuzeh BadrehMohammad Rashno
Nov 5, 2019·Frontiers in Pharmacology·Alexis A GonzalezCarlos P Vio
Mar 4, 2020·Intensive Care Medicine·Haibo ZhangArthur S Slutsky
Mar 7, 2020·Cell Discovery·Yanan CaoWeiqing Wang
Mar 14, 2020·Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases·M L SunG H Su
Mar 15, 2020·The Lancet. Respiratory Medicine·Lei FangMichael Roth
Mar 20, 2020·The FEBS Journal·James L Olds, Nadine Kabbani
Mar 30, 2020·Journal of Medical Virology·Hao ChengGui-Qiang Wang
Apr 1, 2020·The New England Journal of Medicine·Muthiah VaduganathanScott D Solomon
Apr 3, 2020·Journal of the American Heart Association·Rami SommersteinChristoph Gräni
Apr 26, 2020·Cell·Vanessa MonteilJosef M Penninger
Feb 24, 2021·Cell Discovery·Yanan CaoWeiqing Wang
Citations
Oct 21, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Elijah StoneCraig S McLachlan
Feb 10, 2021·Archives of Dermatological Research·Girish Gilly MunavalliMarina Landau
Dec 10, 2020·Clinical and Translational Allergy·Jean BousquetUNKNOWN ARIA group
Mar 21, 2021·Open Heart·James J DiNicolantonioJorge Barroso-Aranda
Apr 8, 2021·Channels·Wentong LongPeter Light
Apr 6, 2021·Frontiers in Pharmacology·Priyanka DashBismita Nayak
Dec 15, 2020·Trends in Biochemical Sciences·Thi Khanh LePalma Rocchi
Apr 20, 2021·Frontiers in Endocrinology·David J EastyBryan T Hennessy
Jun 4, 2021·Tissue Engineering and Regenerative Medicine·Felipe Allan da Silva da CostaJoão Tadeu Ribeiro-Paes
Jun 2, 2021·Journal of Medical Virology·Shireen NigarM Anwar Hossain
Jul 3, 2021·Diseases·Feng XuGuoxun Chen
Jun 18, 2021·World Journal of Stem Cells·Monica Maribel Mata-MirandaGustavo Jesus Vazquez-Zapien
Jul 20, 2021·Journal of Basic and Clinical Physiology and Pharmacology· RufaidaSaba Parveen
Oct 15, 2021·Frontiers in Immunology·Adriana AlbiniDouglas M Noonan